Literature DB >> 2676256

Hypertension and its treatment in the elderly.

J I Robertson1.   

Abstract

Controlled trials have demonstrated the protective effect of antihypertensive drug therapy in subjects over 60 years of age. Elderly patients are often peculiarly sensitive to the side-effects of some antihypertensive drugs, which must therefore be deployed with especial care in this age-group. The widely-supposed differential benefits and acceptability of various drug classes in the elderly have been shown to have been inferred often from inadequate evidence. These aspects require further study. The already large elderly hypertensive population will continue to expand, thus raising important, problematic, but rewarding, therapeutic and economic issues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676256     DOI: 10.3109/10641968909035374

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  4 in total

1.  Should the costs of development inhibit research into new antihypertensive drugs?

Authors:  J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

Review 2.  Angiotensin converting enzyme inhibitors and moderate hypertension.

Authors:  D McAreavey; J I Robertson
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

Review 3.  Epidemiology of hypertension in the elderly.

Authors:  N Morgenstern; R L Byyny
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

Review 4.  The case for antihypertensive drug treatment in subjects over the age of 60.

Authors:  J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.